<DOC>
	<DOCNO>NCT02724670</DOCNO>
	<brief_summary>MR ( Magnetic Resonance Imaging ) - base IGRT ( image-guided radiotherapy ) patient prostate carcinoma .</brief_summary>
	<brief_title>Study MR-based IGRT Prostate Cancer</brief_title>
	<detailed_description>Single arm , phase II study , MR ( Magnetic Resonance Imaging ) - base IGRT ( Image-guided radiotherapy ) prostate cancer . Primary endpoint : Grade 2+ GI ( gastrointestinal ) genitourinary ( GU ) toxicity 2 year .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>histologically proven prostate cancer indication curative treatment ECOG performance scale 02 Informed consent contraindication curative treatment age &lt; 18year previous pelvic radiotherapy prostatic treatment like TURP ( transurethral resection prostate ) , HIFU ( high intensity focus ultrasound ) serious comorbidity lead inability IGRT ( imageguided radiotherapy ) contraindication MRI ( Magnetic Resonance Imaging )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>